Tilray Brands (TLRY) shares rallied to a high of $15.71 (market value > $1.7B) and were trading near $13.05 after jumping ~240% over six months as markets reacted to President Trump’s hint he will sign an executive order to move cannabis from Schedule I to Schedule III. The executive order would ease U.S. commercial opportunities but still requires a lengthy rescheduling process, public comment and would likely face litigation; banking and federal-legal issues would remain until Congress acts. Near-term risks include a likely “sell the news” pullback, ongoing operational headwinds (beverage-segment revenue and gross margin down), and sector-wide regulatory/banking obstacles. Technicals: TLRY bottomed at $7 on Dec. 4, formed a falling wedge and bullish gap, moved above the 50- and 100-day EMAs and the 50% Fibonacci retracement, with RSI nearing overbought — a potential retreat toward ~$10 is noted if profit-taking occurs.

Shares materially rallied on the presidential hint to reschedule cannabis, producing a large short-term price move and clear technical overbought signals; however, the summary notes the rescheduling still requires lengthy administrative steps, public comment and probable litigation and cites operational weakness and ongoing banking/regulatory obstacles, supporting cautious sentiment and a moderate trading impact.